期刊
HUMAN GENOMICS
卷 16, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s40246-022-00383-2
关键词
Diabetes; Single-nucleotide polymorphism; Diagnosis; Middle East
This review assessed the molecular pathology of diabetes in the Middle East population and explored the feasibility of introducing a SNP-based diagnostic panel for diabetes screening. With a population of 370 million, this study could serve as a reliable model for promoting the use of such diagnostic panels in other populations worldwide.
Diabetes is a chronic metabolic disorder that leads to the dysfunction of various tissues and organs, including eyes, kidneys, and cardiovascular system. According to the World Health Organization, diabetes prevalence is 8.8% globally among whom about 90% of cases are type 2 diabetes. There are not any significant clinical manifestations in the primary stages of diabetes. Therefore, screening can be an efficient way to reduce the diabetic complications. Over the recent decades, the prevalence of diabetes has increased alarmingly among the Middle East population, which has imposed exorbitant costs on the health care system in this region. Given that the genetic changes are among the important risk factors associated with predisposing people to diabetes, we examined the role of single-nucleotide polymorphisms (SNPs) in the pathogenesis of diabetes among Middle East population. In the present review, we assessed the molecular pathology of diabetes in the Middle East population that paves the way for introducing an efficient SNP-based diagnostic panel for diabetes screening among the Middle East population. Since, the Middle East has a population of 370 million people; the current review can be a reliable model for the introduction of SNP-based diagnostic panels in other populations and countries around the world.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据